LobbyingOsteal Therapeutics lobbying by quarter
Osteal Therapeutics's latest lobbying report covers Q2 2026, at $100K. The four quarters Q3 2025–Q2 2026 total $190K. Its first report covers Q2 2025; the issues it reports most are Medical/Disease Research/Clinical Labs and Health Issues.
Osteal Therapeutics
- Latest quarter
- $100K
- Q2 2026 · 2 reports
- Last 12 months
- $190K
- Last 4 quarters
- vs last quarter
- +233.3%
- Q2 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $0 | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $100K | 2 |
Policy issues the reports name
- Medical research and clinical labs5 reports
- Health issues1 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
- Food & Drug Administration (FDA)1 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| McGuirewoods Consulting | $130K | 5 quarters |
| Vote America First | $60K | 1 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 09/10for Q2 | Vote America First | $60K |
| 09/09for Q2 | Vote America First | Under $5,000 |
| 07/14for Q2 | McGuirewoods Consulting | $40K |
| 04/14for Q1 | McGuirewoods Consulting | $30K |
| 01/12for Q4 2025 | McGuirewoods Consulting | $30K |
| 25/10/14for Q3 2025 | McGuirewoods Consulting | $30K |
| 25/07/28for Q2 2025 | McGuirewoods Consulting | Under $5,000 |
| 25/07/28for Q2 2025 | McGuirewoods Consulting | Under $5,000 |